Back to search
FDAFDA · Food and drugs·Recall number D-0577-2018

Atropine Sulfate Ophthalmic 1% Solution, USP, 5mL per bottle, Sterile, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC: 17478-215-05

Published March 14, 2018 · Recall initiated: February 21, 2018

Summary

FDA records drug Class III recall D-0577-2018, published March 14, 2018 and initiated February 21, 2018. Recalling firm: Akorn, Inc.; Status: Terminated; Reported quantity: 31,812 bottles; Lot: Lot: 011037A. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Stability Specification: OOS low viscosity results discovered during retain testing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Akorn, Inc.
Distributor
Nationwide in the USA
Lot
Lot: 011037A
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Atropine Sulfate Ophthalmic 1% Solution, USP, 5mL per bottle, Sterile, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC: 17478-215-05 recalled?

Yes. FDA published recall D-0577-2018 on March 14, 2018. Reported hazard: Failed Stability Specification: OOS low viscosity results discovered during retain testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter